🟢 Pharming Group is trading 5% up today after preliminary Q3 revenue topped market expectations

Pharming Group is trading at €0.90, up 5.34%, after preliminary Q3 revenue exceeded market expectations.

• On October 22, the company announced preliminary Q3 revenue of US$117.6 million, up about 21% year over year.
• It cited strong RUCONEST and Joenja performance, narrowed its 2026 revenue outlook and lowered operating-expense guidance.
• Full Q3 results are scheduled for October 27.